Chester-Le-Street, United Kingdom

Helen Routledge

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helen Routledge. Retrieved from https://idiyas.com/inventor/helen-routledge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helen Routledge: Innovator in Pharmaceutical Chemistry

Introduction

Helen Routledge is a notable inventor based in Chester-Le-Street, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her work on various chemical derivatives. Her innovative spirit and dedication to research have led to the development of valuable patents.

Latest Patents

Helen holds a patent for "Imidazole, triazole and tetrazole derivatives." This patent showcases her expertise in creating compounds that have potential applications in medicine and other industries. With 1 patent to her name, she has established herself as a key figure in her field.

Career Highlights

Helen is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. Her role at Merck allows her to collaborate with other talented professionals and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Throughout her career, Helen has worked alongside esteemed colleagues such as Victor G Matassa and Austin John Reeve. These collaborations have enriched her research and expanded the impact of her innovations.

Conclusion

Helen Routledge exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and work at Merck Sharp & Dohme Corporation highlight her commitment to advancing science and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…